CDK4 and melanoma: These activating mutations of CDK4 (R24C and R24H), in the p16INK4a binding domain, as well as inhibitory mutations in p16INK4a in the germline lead to a 50-fold increase in the risk of developing melanoma [8] [9] [10] [11].